Kathmere Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$155K Buy
31,526
+1,735
+6% +$9.31K 0.01% 655
2026
Q1
$161K Buy
29,791
+17,001
+133% +$102K 0.01% 593
2025
Q4
$88.9K Buy
+12,790
New +$84.1K 0.01% 548

Other funds holding BHC

Kathmere Capital Management's BHC Position: Q2 2026 in Review

Kathmere Capital Management increased its Bausch Health (BHC) stake by 5.8% in Q2 2026, buying an estimated $9.31K and bringing the position to 31,526 shares worth $155K. The position accounts for 0.01% of the portfolio, ranked #655.

Kathmere Capital Management first reported a position in BHC in Q4 2025 and has held it in 3 quarters since. The position peaked at $161K in Q1 2026. 71 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • Kathmere Capital Management held 31,526 shares of Bausch Health worth $155K as of Q2 2026.
  • Kathmere Capital Management bought 1,735 Bausch Health shares in Q2 2026, an estimated $9.31K.
  • Bausch Health made up 0.01% of Kathmere Capital Management's portfolio in Q2 2026, its #655 holding.
  • Kathmere Capital Management first reported a position in Bausch Health in Q4 2025 and has held it in 3 quarters since.
  • Kathmere Capital Management's Bausch Health position peaked at $161K in Q1 2026.
  • 71 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Kathmere Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.